In the last year, the FDA has approved two STD tests for at-home use that allow women to get fast diagnoses for syphilis, ...

Chlamydia trachomatis is the most prevalent ... Ears: Patent canal, gray Tempanic Membrane (TM) with positive light reflex. Nose: Patent. Mouth: Palate intact, moist pink mucous membranes ...

If you're sexually active, the Centers for Disease Control and Prevention recommend that you get tested for chlamydia and other sexually transmitted diseases once a year. If you test positive for ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

This approval follows authorization of the first at-home syphilis test last year and authorization of the first diagnostic test for chlamydia and gonorrhea with ... The FDA notes that women with ...

They must have a sensitivity of at least 95%, meaning they correctly identify at least 95% of positive cases. Touch Biotechnology states the at-home chlamydia and gonorrhea test has more than 99% ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for chlamydia, gonorrhea and trichomoniasis.

With our programme, we aim to make chlamydia a preventable disease through vaccination.” A separate vaccine candidate has already demonstrated positive results in a randomised Phase I trial ...

Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and ...

Thirty-five to 50% of infants born to mothers who test positive for clamydia develop chlamydial conjunctivitis, and 11 to 20% of these children develop pneumonia. [3] The initial watery mucoid ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...